Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Trastuzumab Product Approval Information - Licensing Action 12/11/01

Proper name: Trastuzumab
Tradename: Herceptin
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Revised package insert to include updated median survival data
Approval Date: 12/11/2001
Type of submission: Biologics license application supplement

 

Approval Letter (PDF)

Label (PDF)

-
-